This contract expires in 111 days (Dec 31, 2026).
CARDINAL HEALTH 414, LLC - GALLIUM DOTATATE 68 OY 2 FUNDING
Key Details
Description
GALLIUM DOTATATE 68 OY 2 FUNDING
Context & Analysis
On Feb 9, 2026, Department of Veterans Affairs obligated $137,676.6 to CARDINAL HEALTH 414, LLC for gallium dotatate 68 oy 2 funding. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in DUBLIN, OH. The contract is scheduled through Dec 31, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.